Table 1.
Parathyroid hormone targets indicated by professional organizations guidelines
| Professional Organization | Year Published | PTH Target Level (pg/ml) |
|---|---|---|
| Europe | ||
| European Renal Association–European Dialysis and Transplant Association (42) | 2000 | 85–170 |
| United Kingdom Renal Association (43) | 2002 | <4 times upper normal rangea |
| North America | ||
| National Kidney Foundation (18) | 2003 | 150–300 |
| Canadian Society of Nephrology (44) | 2006 | 100–500 |
| Kidney Disease Outcomes Quality Initiative United States commentary (17) | 2010 | 130–600 |
| Australia/New Zealand | ||
| Australian and New Zealand Society of Nephrology (45,46) | 2006 | 1–3 times upper normal rangeb |
| Japan | ||
| Japanese Society for Dialysis Therapy (35) | 2008 | 60–180 |
| Japanese Society for Dialysis Therapy (36) | 2012 | 60–240 |
| Worldwide | ||
| Kidney Disease Improving Global Outcomes (16) | 2009 | 2–9 times upper normal rangec |
a
For example, <260 pg/ml on the basis of an upper limit of the normal range of 65 pg/ml.
b
For example, this could be approximated to 65–195 pg/ml on the basis of an upper limit of the normal range of 65 pg/ml.
c
For example, this could be approximated to 130–585 pg/ml on the basis of an upper limit of the normal range of 65 pg/ml.